Moderator: Brad Perkins, Chief Medical Officer, Human Longevity, MD, MBA
Panelists: Werner Verbiest, Global Head – Janssen Diagnostics, Thomas Bock, MD, MBA, Chairman & CEO HeritX, Marian Rewers, MD, PhD, Executive Director, Barbara Davis Center for Childhood Diabetes University of Colorado School of Medicine, David S. Karow, Ph.D., MD, Chief Medical Imaging Officer, Human Longevity, Inc.
Precision medicine’s greatest value may derive from shifting our unprecedented tools and technologies from the back end of diseases (treating diseases and their systems) to their front end: pre-disease interception and disease prevention. Leaders from academia, industry and philanthropy describe how this vision is already being implemented in cancer, diabetes and others fields affecting billions of people around the world. The panel will discuss opportunities, hurdles to overcome, and collaborative efforts across traditional boundaries to make reality that people can stay healthy and lead productive lives.